Evidence map›Paper›PMID 42466659›Full record

Observational studyCancer control : journal of the Moffitt Cancer Center

Incidence, Trends, and Racial/Ethnic Disparities in Female Breast Cancer in the United States, 2000-2023: A SEER Based Study.

Nompumelelo O Mzizi, Sandile S Ndabezitha, Julie A Atta, Mohammad A Al Zoubi, Sreelatha Akkala

Abstract readObservational Study
In one paragraph

Observational study in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nompumelelo O MziziSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0001-5052-6893
Sandile S NdabezithaSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Julie A AttaSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Mohammad A Al ZoubiSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0001-8299-4157
Sreelatha AkkalaSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0003-4061-9839

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionIn 2026, an estimated 321,910 new cases of invasive breast cancer will be diagnosed.However, there is a lack of comprehensive data on breast cancer incidence trends and how they vary across different age groups and racial and ethnic populations. Existing studies have evaluated breast cancer incidence trends over short periods, resulting in a lack of clear information on specific population variations over extended periods to ascertain disease-specific trends.MethodsWe used the 2000-2023 Surveillance, Epidemiology, and End Results program dataset to analyze routine data and published cancer cases to identify incidence trends and disease burden by age and race/ethnicity using Joinpoint regression. We included new cases of breast cancer identified using International Classification of Diseases (ICD) codes. Patient's demographic information was obtained from the medical records.ResultsThe overall breast cancer incidence among women was 190.8 per 100,000, showing an increasing trend from 2000 to 2023. There was also a significant increase in age-adjusted incidence rates in breast cancer trends from 2000 to 2023 (AAPC = 0.76%), with the highest incidence being reported in women aged 75-⁠79 years (456.3 per 100,000). Non-Hispanic white women recorded the highest incidence over the period (228.9 per 100,000). Non-Hispanic White women experienced increasing incidence trends between 2000 and 2023 (AAPC = 0.76%).ConclusionFrom 2000 to 2023, there was a significant increase in breast cancer incidence trends in all groups, with notable rates among women in their 40s and above. These trends underscore the need for adaptive screening strategies and policy recommendations to initiate mammography at age 40. Progress could also be accelerated by understanding the associations among ethnic, racial, and other existing social disparities to ensure early diagnosis and treatment.

Indexed as

Breast NeoplasmsEthnicityHealth Status DisparitiesRacial GroupsAdultAgedAged, 80 and overFemaleHumansIncidenceMiddle AgedSEER ProgramUnited Statesbreast cancerburdenepidemiologyincidence; SEER; United States

Identifiers

PMID42466659
PMCPMC13379643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.